New Treatment of Meibomian Gland Dysfunction (MGD) Cleared for FDA Approval


Meibomian Gland Dysfunction FDA Treatment

Sight Sciences announced clearance of the TearCare System for the treatment of meibomian gland dysfunction (MGD), the leading cause of dry eye disease (DED).

Contact the Dry Eye Center of Maryland to learn more and schedule your appointment.


Schedule Your Dry Eye Consultation Today!
(410) 291-1718